AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Vaccine cost-effective in preventing secondary hepatitis A infection.
2003 NOV 12 - (NewsRx.com & NewsRx.net) -- Vaccination is cost-effective in preventing secondary hepatitis A infection.
According to recent research from France, "Using a decision-tree based model, we investigated the cost-effectiveness of several vaccination strategies for household, day care center, and nursery/primary school contacts of primary cases of hepatitis A in France. Depending on the age groups vaccinated, the cost per symptomatic case avoided varied between Euro 700 and 1300 (Euro 1 = US $0.93) for household contacts."
"Vaccination of contacts in day care centers and schools resulted in cost-savings," concluded Marc Pechevis and collaborators at GlaxoSmithKline and the consulting firm CEMKA-EVAL. "However, these findings are contingent on the limited and controversial data available on vaccine protective efficacy. In ...
- Stopping Hepatitis A in Families.
- Magazine article from: Family Practice News May 15, 1999 700+ words
...Pausilipon, Naples, Italy, and his associates (Lancet 353[9159]:1136-39, 1999). For every case of secondary hepatitis A virus infection averted, 18 family members had to be vaccinated in this randomized, nonblinded study.
- Epstein-Barr virus infection-associated hemophagocytic lymphohistiocytosis:...
- Magazine article from: Reactions Weekly Anonymous August 30, 2008 700+ words
...IgM against viral capsid antigen was positive indicating recent EBV infection. Infectious mononucleosis with secondary hepatitis and bone marrow suppression was diagnosed. Azathioprine was withdrawn and infliximab held. Her increased temperature...
